References
- Gibbons RV, Vaughn DW. Dengue: an escalating problem. Br Med J 2002; 324: 1563–6
- World Health Organisation. Dengue and dengue haemorrhagic fever. Fact sheet No. 117, Revised April 2002. http://www.who.int/inf-fs/fr/am117.htlm.
- Mairuhu ATA, Wagenaar J, Brandjes DPM, van Gorp ECM. Dengue: an arthropod-borne disease of global importance. Eur J Clin Microbiol Infect Dis 2004; 23: 425–33
- World Health Organisation (1997). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edn. WHO, Geneva.
- Wilder-Smith A, Schwartz E. Dengue in travellers. NEJM 2005; 353: 924–32
- Murgue B, Deparis X, Chungue E, Cassar O, Roche C. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Tropical Medicine and International Health 1999; 11: 765–73
- Lanciotti RS, Calisher CH, Gubler DJ, Chang G-J, Vordam AV. Rapid detection and typing of dengue viruses from clinical samples using reverse transcriptase chain reaction. J Clin Microbiol 1992; 30: 545–55
- Wills BA, Dung NM, Loan HT, Tam DTH, Thuy TTN, Minh LTT, et al. Comparison of 3 fluid solutions for resuscitation in dengue shock syndrome. NEJM 2005; 353: 877–89
- Wichman O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana, Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Tropical Medicine and International Health 2004; 9: 1022–9
- Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue haemorraghic fever in infants. Am J Trop Med Hyg 1988; 38: 411–9
- Guzman MG, Kouri GP, Bravo J, Soler M, Vasquez S, Morier L. Dengue haemorrhagic fever in Cuba. A retrospective sero-epidemiological study. Am J Trop Med Hyg 1990; 42: 179–84
- Wahid SF, Sanusi S, Zawawi MM, Ali RA. A comparison of the pattern of liver involvement in dengue haemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health 2000; 31: 259–63
- Pancharoen C, Rungsarannont A, Thisyakorn U. Hepatic dysfunction in dengue patients with varying severity. J Med Assoc Thai 2002; 85(Suppl. 1)298–301
- van Gorp ECM, Suharti C, Mairuhu ATA, Dolmans WMV, van der Ven J, Demacker PNM, van der Mer JWM. Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue haemorraghic fever. CID 2002; 34: 1150–3
- Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viraemia titre, antibody response pattern, and virus serotype correlate with disease severity. JID 2000; 181: 2–9
- Murgue B, Roche C, Chungue E, Deparis X. Prospective study of the duration and magnitude of viraemia children hospitalized during the 1996–1997 dengue 2 outbreak in French Polynesia. J Med Virol 2000; 60: 432–8
- Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus non-structural protein NS1 early in dengue haemorrhagic fever. JID 2002; 186: 1165–8
- Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to dengue virus type 1 non-structural NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002; 40: 376–81
- Murgue B, Cassar O, Deparis X. Plasma concentrations of sVCAM-1 and severity of dengue infections. J Med Virol 2001; 65: 97–104
- Koraka P, Murgue B, Deparis X, van Gorp EC, Setiati TE, Osterhaut Groen J. Elevation of soluble VCAM-1 plasma levels in children with a dengue virus infection of varying severity. J Med Virol 2004; 72: 445–50